Skip to content

A Multi-domain Approach for the Characterization and Early Diagnosis of Neurodevelopmental Disorders

A Multi-domain Approach for the Characterization and Early Diagnosis of Neurodevelopmental Disorders

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05269927
Enrollment
300
Registered
2022-03-08
Start date
2016-03-01
Completion date
2021-05-31
Last updated
2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurodevelopmental Disorders

Keywords

Neurodevelopmental disorder, EEG, Multi-domain data, Machine Learning

Brief summary

Diagnosis and characterization of neurodevelopmental disorders are considered challenging processes because of their complexity, multi-factoriality and heterogeneity. The present project will consider two of the most common neurodevelopmental disorders (i.e. autism spectrum disorders (ASD) and language disorders (LD)), with the aim to overcome these difficulties, by: a) deeply investigating their neuronal correlates; b) identifying multi-domain biomarkers (electrophysiological, genetic, environmental and clinical); c) developing a machine learning algorithm for early diagnosis. To achieve the above mentioned aims a multi-domain dataset will be used, comprising data collected from typically developing infants, infants at high risk for ASD and infants at high risk for LD. The data that will be used have been already collected within other trials performed at the Scientific Institute E. Medea.

Interventions

DIAGNOSTIC_TESTEEG

resting state EEG

DIAGNOSTIC_TESTDNA samples

genotypings of twelve CNTNAP2 SNPs from DNA obtained by saliva samples

DIAGNOSTIC_TESTclinical data

standardized scales measuring the infants' cognitive, motor and linguistic development administered at 6, 12 and 18. Measures available at 6 and 12 months: a) Bayley Scales of Infant and Toddler Development- Third Edition; b) Griffiths mental development scales (0-2) (GMDS-R); Measures available at 18 months: c) Language Development Survey (LDS); d) Il PRIMO VOCABOLARIO DEL BAMBINO (PVB); e) CHILD BEHAVIOR CHECKLIST (CBCL); (f) Modified Checklist for Autism in Toddlers (M-CHAT).

OTHERenvironmental data

questionnaires administered to parents related to the following environmental factors: a) information about the presence of a clinical diagnosis of neurodevelopmental disorders within first-degree relatives; b) gestational age; c) birth weight; d) parental age and education; e) socio-economic status

Sponsors

Ministry of Health, Italy
CollaboratorOTHER_GOV
IRCCS Eugenio Medea
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Months to 7 Months
Healthy volunteers
Yes

Inclusion criteria

* APGAR scores at birth at 1' and 5' \> 7; * newborn screening otoacoustic emissions in the norm; * absence of neurological disorders; * Italian as the language mainly spoken in the family nucleus.

Exclusion criteria

* APGAR scores at birth at 1' and 5' \<= 7; * newborn screening otoacoustic emissions not in the norm; * presence of neurological disorders; * non-Italian native speaker

Design outcomes

Primary

MeasureTime frameDescription
EEG power spectral density (PSD)one year after the end of the recruitmentPower spectral density (PSD) estimated in the delta, theta, alpha, beta and gamma frequency bands of the EEG
EEG signal coherence18 months after the end of the recruitmentEEG signal coherence
EEG signal entropy18 months after the end of the recruitmentEEG signal entropy

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026